Authors:
Wolfers, J
Lozier, A
Raposo, G
Regnault, A
Thery, C
Masurier, C
Flament, C
Pouzieux, S
Faure, F
Tursz, T
Angevin, E
Amigorena, S
Zitvogel, L
Citation: J. Wolfers et al., Tumor-derived exosomes are a source of shared tumor rejection antigens forCTL cross-priming, NAT MED, 7(3), 2001, pp. 297-303
Authors:
Motta, I
Andre, F
Lim, A
Tartaglia, J
Cox, WI
Zitvogel, L
Angevin, E
Kourilsky, P
Citation: I. Motta et al., Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canarypox virus-infected dendritic cells, J IMMUNOL, 167(3), 2001, pp. 1795-1802
Authors:
Merad, M
Angevin, E
Wolfers, T
Flament, C
Lorenzi, I
Triebel, F
Escudier, B
Zitvogel, L
Citation: M. Merad et al., Generation of monocyte-derived dendritic cells from patients with renal cell cancer: Modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2 and IL-12), J IMMUNOTH, 23(3), 2000, pp. 369-378
Authors:
Thery, C
Regnault, A
Garin, J
Wolfers, J
Zitvogel, L
Ricciardi-Castagnoli, P
Raposo, G
Amigorena, S
Citation: C. Thery et al., Molecular characterization of dendritic cell-derived exosomes: Selective accumulation of the heat shock protein hsc73, J CELL BIOL, 147(3), 1999, pp. 599-610
Authors:
Zitvogel, L
Tahara, H
Mayordomo, JI
Storkus, WJ
Robbins, PD
Elder, EM
Whiteside, TL
Lotze, MT
Citation: L. Zitvogel et al., Specific active immunotherapy for cancer: gene or dendritic cell-based tumor vaccines - Preclinical studies and clinical trials, RESEARCH IN, 1998, pp. 475-494
Authors:
Zitvogel, L
Fernandez, N
Lozier, A
Wolfers, J
Merad, M
Angevin, E
Amigorena, S
Escudier, B
Citation: L. Zitvogel et al., Immunotherapy for cancer by dendritic cell therapy - From preclinical bases to therapeutic trial designs, EUROCANCER 98, 1998, pp. 289-291